BARCELONA, Spain – Even if the myriad uncertainties that have accompanied the arrival of the Trump administration in the U.S. mean that business as usual may no longer be possible for many biopharma firms, they still have business to conduct. And that was foremost in the mind of delegates arriving at Barcelona’s International Convention Center (CCIB) Monday.